Impact of Standard or Increased Moxifloxacin Dose Among MDR-TB Patients in Mumbai with Low-Level Resistance

Post Date: 
2019-02-04
   |   
Countries: 
   |   
Clinical Sites: 
Summary: 

Tornheim JA, Udwadia ZF, Porwal S,  Kishore G,  Gajjar I,  Karane M,  Shivakumar SVBY, Rodrigues C, Gupta A. Impact of Standard or Increased Moxifloxacin Dose Among MDR-TB Patients in Mumbai with Low-Level Resistance. 8th Annual Regional Prospective Observational Research for Tuberculosis (RePORT) India Joint Leadership Meeting – ‘’Biomarkers and Beyond.” Chennai, India. February 4-6, 2019.